Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COAG

Hemab Therapeutics Holdings Inc

May 06 • 04:00PM ET

25.01

+0.01 0.04 %

Healthcare • Biotechnology • USA • Nano • NASD

Held by: TMSL

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	2.01M	Perf Week	-
Market Cap	44.52M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-26.44%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	36.61 -31.69%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	23.81 5.04%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	5.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-8.51%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-8.51%	Rel Volume	0.33	Prev Close	25.00
Employees	72	LT Debt/Eq	-	Earnings	-	SMA200	-8.51%	Avg Volume	1.72M	Price	25.01
IPO	May 01, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	569,415	Change	0.04%

May-04-26 04:01PM

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

(GlobeNewswire) -25.47%

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded on February 12, 2026 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RA CAPITAL MANAGEMENT, L.P.	Director	May 04 '26	Buy	18.00	2,675,000	48,150,000	6,149,096	May 06 07:16 PM
RA CAPITAL MANAGEMENT, L.P.	Director	May 05 '26	Buy	24.63	97,411	2,399,546	6,246,507	May 06 07:16 PM
RA CAPITAL MANAGEMENT, L.P.	Director	May 06 '26	Buy	24.60	68,018	1,673,399	6,314,525	May 06 07:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COAG

Hemab Therapeutics Holdings Inc

Upgrade your Finviz experience